Beta-blocker treatment guided by head-up tilt test in neurally mediated syncope

Current Therapeutic Research - Clinical and Experimental

Volumn 58, Issue 11, 1997, Pages 842-850

  Boriani, Giuseppe ^a,b   Biffi, Mauro ^a   Bronzetti, Gabriele ^a   Sabbatani, Paolo ^a   Branzi, Angelo ^a   Magnani, Bruno ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Beat blockers; Head up tilt test; Neurally mediated syncope

Indexed keywords

ISOPRENALINE; METOPROLOL; PROPRANOLOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEAD TILTING; HUMAN; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RECURRENT DISEASE; REPRODUCIBILITY; SYNCOPE; TILTING; TITRIMETRY;

EID: 0031415391     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(97)80050-1     Document Type: Article

References (22)

1. Kenny RA, Ingram A, Bayliss J, et al. Head-up tilt: A useful tool for investigating unexplained syncope. Lancet. 1986;1:1352-1355.
2. Morillo CA, Klein GJ, Gersh BJ. Can serial tilt testing be used to evaluate therapy in neurally mediated syncope? Am J Cardiol. 1996;77:521-523.
3. Morillo CA, Leitch JW, Yee R, et al. A placebo controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope. J Am Coll Cardiol. 1993;22: 1843-1848.
4. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in vasovagal syncope: Results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol. 1995;25:65-69.
5. Fitzpatrick AP, Ahmed R, Williams S, et al. A randomized trial of medical therapy for vasodepressor vasovagal syncope. Eur J Card Pacing Electrophysiol. 1991;2:43-48.
6. Brignole M, Menozzi C, Gianfranchi L, et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol. 1992;70:339-342.
7. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: A comprehensive literature review. Am J Med. 1994;97:78-88.
8. Sutton R, Petersen M, Brignole M, et al. Proposed classification for tilt induced vasovagal syncope. Eur J Card Pacing Electrophysiol. 1992;2:109-113.
9. Fitzpatrick AP, Theodorakis G, Vardas P, et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J. 1991;12:389-394.
10. Decter BM, Goldner B, Cohen TJ. Vasovagal syncope as a cause of motor vehicle accidents. Am Heart J. 1994;127:1619-1621.
11. Sheldon R, Spalwinski J, Killman S. Reproducibility of isoproterenol tilt table test. Results in patients with syncope. Am J Cardiol. 1992;69:1300-1305.
12. Grubb BP, Wolfe D, Temesy-Armos P, et al. Reproducibility of head-upright tilt table results in patients with syncope. PACE. 1992;15:1477-1481.
13. Chen XC, Chen MY, Remole S, et al. Reproducibility of head-up tilt table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol. 1992;69:755-760.
14. Natale A, Akhtar M, Jazayeri M, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation. 1995;92:54-58.
15. Benditt DG, Petersen M, Lurie KG, et al. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med. 1995;122:204-209.
16. Sra JS, Jazayeri MR, Avitall B, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. NEJM. 1993;328:1085-1090.
17. Abboud FM. Neurocardiogenic syncope. NEJM. 1993;328:1117-1119.
18. Rea RF, Thames MD. Neural control mechanisms and vasovagal syncope. J Cardiovasc Electrophysiol. 1993;4:587-595.
19. Lippman N, Stein KM, Lerman BB. Differential therapeutic responses of patients with isoproterenol-dependent and isoproterenol-independent vasodepressor syncope. Am Heart J. 1994;128:1110-1116.
20. Grubb BP, Temesy-Armus P, Hahn H, et al. Utility of head upright tilt table testing in the evaluation and management of syncope of unknown origin. Am J Med. 1991;90:6-10.
21. Mahanonda N, Bhuripanyo K, Kangkagate C, et al. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J. 1995;130:1250-1253.
22. Dangovian HI, Jarandilla R, Frumin H. Prolonged asystole during head-up tilt table testing after beta-blockade. PACE. 1992;15:14-16.